🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Fulgent Genetics, Inc.

FLGT Healthcare
$20.1 +$0.11 (0.55%)
Market Cap: $553.06 M
Gurus Holding
4
Popularity Rank
#2112
% of Shares Held
1.49%
Net Activity (Q2 2026)
+$5.29 M

Guru Ownership Trend

Guru Analysis for Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics, Inc. (FLGT), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q2 2026, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $8.27 M.

Top institutional holders include Steven Cohen and Paul Tudor Jones.

Institutional sentiment is currently Bullish. This is evidenced by a $5.29 M net inflow during the quarter.

Recent activity highlights Cliff Asness who increased their stake by 135.9%.

Key Holders

Top 5 by Value

$4.34 M
$1.43 M

Top 5 by Conviction

Recent Activity Breakdown (Q2 2026)

+$5.57 M
Total Buy Value
New Buys 1
Additions 3
-$286,200
Total Sell Value
Reductions 0
Sold Out 1

Guru Consensus (Q2 2026)

Based on recent activity
Net Sellers
1
Net Buyers
4

FAQs for Fulgent Genetics, Inc. (FLGT)

Major holders include Steven Cohen ($4.34 M), Paul Tudor Jones ($1.68 M), Cliff Asness ($1.43 M). According to the latest reported data, 4 tracked investment managers collectively hold approximately 411,231 shares.

According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $5.29 M, with 4 managers increasing positions and 1 managers reducing holdings.

During the most recent reporting period, 0 managers trimmed their positions, while 1 fully exited FLGT. The total reported sell value was $286,200.

Yes, 1 managers opened new positions in FLGT, and 3 increased their existing holdings. The total reported buy value was $5.57 M.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.00% New Buy 211,708 $4.34 M Q2 2026
0.00% Add 27.5% 81,727 $1.68 M Q2 2026
0.00% Add 135.9% 69,453 $1.43 M Q2 2026
0.01% Add 4.8% 48,343 $991,998 Q2 2026
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form